Japan Lifeline Co., Ltd. (TYO:7575)
1,496.00
-26.00 (-1.71%)
Mar 11, 2025, 3:30 PM JST
Japan Lifeline Revenue
Japan Lifeline had revenue of 14.83B JPY in the quarter ending December 31, 2024, with 12.57% growth. This brings the company's revenue in the last twelve months to 55.89B, up 8.42% year-over-year. In the fiscal year ending March 31, 2024, Japan Lifeline had annual revenue of 51.38B, down -0.71%.
Revenue (ttm)
55.89B
Revenue Growth
+8.42%
P/S Ratio
1.94
Revenue / Employee
45.96M
Employees
1,216
Market Cap
105.64B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 51.38B | -366.00M | -0.71% |
Mar 31, 2023 | 51.75B | 281.00M | 0.55% |
Mar 31, 2022 | 51.47B | 183.00M | 0.36% |
Mar 31, 2021 | 51.29B | -475.00M | -0.92% |
Mar 31, 2020 | 51.76B | 6.24B | 13.70% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |